PLC and HMI modernization services for pharmaceutical manufacturers. The engagement covers the risk assessment, the validation strategy, the phased execution, the operating routine, and the post-modernization support.
The PLC and HMI modernization is a high-risk project due to the production impact, the validation requirements, and the operational complexity.
The validation strategy defines the URS, FDS, IQ, OQ, PQ, the change control, the periodic review, and the validation maintenance.
The modernization is executed in phases: pilot line, second line, full site.
The operating routine covers the system administration, the change control, the periodic review, the cybersecurity, and the lifecycle management.
Use this PLC and HMI Modernization page as a planning checkpoint before vendor selection, architecture review, validation scoping or implementation sequencing. The strongest next step is to compare the guidance with your current SOPs, system inventory, batch records, data flows and QA review routines so the discussion starts from evidence instead of assumptions.
For PLC and HMI Modernization, prepare the records, owners, risks and decision criteria linked to modernization risk assessment, validation strategy, phased execution, operating routine. Useful evidence includes current process maps, interface lists, audit trail expectations, exception workflows, data retention rules and the business reason for changing the current operating model.
Modernization is necessary when the legacy PLC and HMI are at end of life, when the cybersecurity risk is unacceptable, when the production process requires new functionality, or when the operational cost of the legacy system is too high.
Production impact is managed through the phased execution, the production schedule, the temporary systems, the rollback plan, and the operational support.